Clinicien(ne) chercheur(e)

Dr Eric Larose

Cardiologie

A1122

eric.larose@criucpq.ulaval.ca

Domaine de recherche

Athérosclérose, imagerie cardiovasculaire avancée, adiposité viscérale, activité physique, facteurs de risque

Description des travaux

Le programme de recherche en imagerie cardiovasculaire avancée du Dr Éric Larose s'articule autour de l'athérosclérose et de son dépistage avant qu'elle n'évolue vers l'infarctus du myocarde, l'accident vasculaire cérébral ou la mort subite. Les travaux de son équipe visent donc à identifier, à l'aide de la résonance magnétique et de la tomographie axiale, les déterminants et les conséquences de la biologie vulnérable de l'athérosclérose dans une population variée, incluant des sujets hommes et femmes sains, des sujets avec athérosclérose asymptomatique, des sujets avec symptômes chroniques et des sujets avec symptômes aigus. Ses travaux de recherche visent également à clarifier si un programme de modification des habitudes de vie, dont l'efficacité clinique est rapportée, peut amener une régression de l'athérosclérose et des caractéristiques de vulnérabilité de la plaque. Finalement, le programme cherche à identifier les différences entre l'évolution de la taille de la plaque et l'évolution des caractéristiques de vulnérabilité de la plaque.

Ce programme de recherche est subventionné sans arrêt depuis 9 ans par les organismes provinciaux et nationaux incluant la Fondation des maladies du coeur du Canada, le Fonds de recherche du Québec - Santé et les Instituts de recherche en santé du Canada, et a mené à la publication de plus de 115 manuscrits originaux. L'équipe du Dr Larose a encadré plus de 25 étudiants gradués (M.Sc. et Ph.D.) et stagiaires post-doctoraux (fellow) assurant une formation polyvalente en recherche clinique, en imagerie et intervention cardiovasculaires.

Prix et distinctions

07/2013 - 06/2017 : Chercheur-bouriser clinicien - Junior 2, Fonds de recherche du Québec - Santé (FRQS), Canada. L’impact de l’activité physique sur l’évolution de l’athérosclérose chez les hommes et les femmes : de la prévention secondaire à la prévention primordiale
07/2010 - 06/2011 : Prix d’excellence en cardiologie préventive, Fondation des maladies du coeur (FMC), Canada "Is vulnerable atherosclerosis a local or a systemic phenomenon?"
07/2009 - 06/2013 : Chercheur-boursier clinicien - Junior 1, Fonds de recherche du Québec - Santé (FRQS), Canada. Déterminants et conséquences de l’athérosclérose vulnérable
07/2008 - 06/2009 : Prix d’xxcellence en cardiologie préventive, Fondation des maladies du coeur (FMC), Canada "Is vulnerable atherosclerosis a local or a systemic phenomenon?"
01/2008 : Prix Coeur Québec, Fondation des maladies du coeur (FMC), Canada
07/2006 - 06/2009 : Prix du jeune chercheur, Faculté de médecine, Université Laval, Canada Characterization of vulnerable atherosclerosis
07/2005 : Finaliste, Prix Linnemeier - Jeune chercheur, Conférence Transcatheter Cardiovascular Therapeutics (TCT), Washington, DC, USA
06/2005 : Meilleur résumé, 2005 Annual Intervention Fellow’s Complex Coronary Complications (C3) Summit, Las Vegas, NV, USA
11/2004 : Finaliste, Compétition de résumés - Athérosclerose, Association américaine de cardiologie, USA Intravascular magnetic resonance imaging to characterize the composition of human atherosclerosis plaques in vivo
05/2004 : Prix Paul P. David de l’Association des cardiologues du Québec Association des cardiologues du Québec, Canada
06/2003 - 07/2005: Bourse de formation en recherche post-diplôme professionnel (fellowship), Fonds de recherche du Québec - Santé (FRQS), Canada Identification and characterization of vulnerable plaque by intravascular magnetic resonance imaging
06/2003 - 07/2005 : Bourse Frank A. Dottori de la Fondation de l’Institut de cardiologie de Montréal, Fondation de l’Institut de cardiologie de Montréal, Canada Identification and characterization of vulnerable plaque by intravascular magnetic resonance imaging
05/2003 : Prix Pfizer de l’Association des cardiologues du Québec, Association des cardiologues du Québec, Canada
06/2002 : Prix Fournier de l’Institut de cardiologie de Montréal - Chargé de cours, Institut de cardiologie de Montréal, Canada
06/2003 : Liste d’honneur du doyen - Fellowship en cardiologie, Université de Montréal, Canada
07/1997 - 06/2000 : Liste d’honneur du doyen - Résidence médecine interne, Université de Montréal, Canada
06/1993 : Prix de l’Association canadienne des médecins vétérinaires, Association canadienne des médecins vétérinaires, Canada
06/1993 : Prix Janssen Leadership et esprit sportif, Association des médecins vétérinaires du Québec, Canada

Publications

189

Trier par année :

Larose E, Yeghiazarians Y, Libby P, Yucel EK, Aikawa M, Kacher DF, Aikawa E, Kinlay S, Schoen FJ, Selwyn AP, Ganz P. Characterization of human atherosclerotic plaques by intravascular magnetic resonance imaging.. Circulation 2005; 112(15):2324-31.
Yan AT, Gibson CM, Larose E, Anavekar NS, Tsang S, Solomon SD, Reynolds G, Kwong RY. Characterization of microvascular dyfunction after acute myocardial infarction by cardiac magnetic resonance first-pass perfusion and delayed enhancement imaging.. J Cardiovasc Magn Reson 2006; 8(6):831-7.
Larose E, Ducharme A, Mercier LA, Pelletier G, Harel F, Tardif JC. Prolonged distress and clinical deterioration before pericardial drainage in patients with cardiac tamponade.. Can J Cardiol 2000; 16(3):331-6.
Larose E, Tardif JC, Bourassa MG. Use of ACE Inhibitors for Secondary Prevention.. Curr Treat Options Cardiovasc Med 2003; 5(1):51-61.
Larose E, Ganz P. Statins and endothelial dysfunction.. Semin Vasc Med 2004; 4(4):333-46.
Bertrand OF, De Larochellière R, Rodés-Cabau J, Proulx G, Gleeton O, Nguyen CM, Déry JP, Barbeau G, Noël B, Larose E, Poirier P, Roy L. A randomized study comparing same-day home discharge and abciximab bolus only to overnight hospitalization and abciximab bolus and infusion after transradial coronary stent implantation.. Circulation 2006; 114(24):2636-43.
Larose E, Rogers CD, Simon DI. When size matters: lessons learned from left main stent embolization and retrieval.. J Interv Cardiol 2006; 19(4):350-5.
Larose E. Below radar: contributions of cardiac magnetic resonance to the understanding of myonecrosis after percutaneous coronary intervention.. Circulation 2006; 114(7):620-2.
Bertrand OF, Larose E, De Larochellière, Proulx G, Nguyen CM, Déry JP, Gleeton O, Barbeau G, Noël B, Rouleau J, Boudreau JR, Roy L, Rodés-Cabau J. Outpatients percutaneous coronary intervention: Ready for prime time?. Can J Cardiol 2007; 23(0):58-66B.
Larose E, Ganz P, Reynolds HG, Dorbala S, Di Carli MF, Brown KA, Kwong RY. Right ventricular dysfunction assessed by cardiovascular magnetic resonance imaging predicts poor prognosis late after myocardial infarction.. J Am Coll Cardiol 2007; 49(8):855-62.
Bertrand OF, Larose E, Rodés-Cabau J. Sub-cutaneous nitroglycerin: Good example of the "KISS" rule!. Catheter Cardiovasc Interv 2007; 70(1):161.
Faik I, Mongrain R, Leask RL, Rodés-Cabau J, Larose E, Bertrand OF. Time-dependent 3D simulations of the hemodynamics in a stented coronary artery.. Biomedical Mat 2007; 2(1):28-37.
Rodés-Cabau J, Facta A, Larose E, Delarochellière R, Déry JP, Nanh Guyen C, Roy L, Proulx G, Gleeton O, Barbeau G, Noël B, Rouleau J, Boudreault JR, Bertrand OF. Predictors of aorto-saphenous vein bypass narrowing late after coronary artery bypass grafting.. Am J Cardiol 2007; 100(4):640-5.
Larose E, Rodés-Cabau J, Delarochelliere R, Barbeau G, Noel B, Bertrand O. Cardiovascular magnetic resonance for the clinical cardiologist.. Can J Cardiol 2007; 23(0):84-88B.
Larose E. Magnetic resonance for assessment of atherosclerosis: From bench to bedside.. Cardio Update 2006; 2(0):16-8.
Després JP, Lemieux I, Bergeron J, Pibarot P, Mathieu P, Larose E, Rodés-Cabau J, Bertrand OF, Poirier P. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk.. Arterioscler Thromb Vasc Biol 2008; 28(6):1039-49.
Courtis J, Rodés-Cabau J, Larose E, Déry JP, Nguyen CM, Proulx G, Gleeton O, Roy L, Barbeau G, Noël B, DeLarochellière R, Bertrand OF. Comparison of medical treatment and coronary revascularization in patients with moderate coronary lesions and borderline fractional flow reserve measurements.. Catheter Cardiovasc Interv 2008; 71(4):541-8.
Mathieu P, Pibarot P, Larose E, Poirier P, Marette A, Després JP. Visceral obesity and the heart.. Int J Biochem Cell Biol 2008; 40(5):821-36.
Bertrand OF, Faurie B, Larose E, Nguyen CM, Gleeton O, Déry JP, Noël B, Proulx G, Roy L, Costerousse O, De Larochellière R, Rodes-Cabau J. Clinical Outcomes after Multilesion Percutaneous Coronary Intervention: Comparison between Exclusive and Selective Use of Drug-Eluting Stents.. J Invasive Cardiol 2008; 20(3):99-104.
Brunette J, Mongrain R, Rodés-Cabau J, Larose E, Leask R, Bertrand OF. Comparative rheology of low- and iso-osmolarity contrast agents at different temperatures.. Catheter Cardiovasc Interv 2008; 71(1):78-83.
Pibarot P, Larose E. What our eyes see is not necessarily what our heart feels.. Cardiology 2008; 109(2):122-5.
Larose E, Kinlay S, Selwyn AP, Yeghiazarians Y, Yucel EK, Kacher DF, Libby P, Ganz P. Improved characterization of atherosclerotic plaques by gadolinium contrast during intravascular magnetic resonance imaging of human arteries.. Atherosclerosis 2008; 196(2):919-25.
Garceau P, Déry JP, Lachance P, Grenier S, Rodés-Cabau J, Barbeau G, Bertrand OF, Gleeton O, Larose E, Nguyen CM, Noël B, Proulx G, Roy L, de Larochellière R. Treatment delays in patients undergoing primary percutaneous coronary intervention for ST elevation myocardial infarction at the Quebec Heart and Lung Institute.. Can J Cardiol 2007; 23(0):53-57B.
Mongrain R, Faik I, Leask RL, Rodés-Cabau J, Larose E, Bertrand OF. Effects of diffusion coefficients and struts apposition using numerical simulations for drug eluting coronary stents.. J Biomech Eng 2007; 129(5):733-42.
Brulotte S, Roy L, Larose E. Congenital absence of the pericardium presenting as acute myocardial necrosis.. Can J Cardiol 2007; 23(11):909-12.
Steel K, Broderick R, Gandla V, Larose E, Resnic F, Jerosch-Herold M, Brown KA, Kwong RY. Complementary prognostic values of stress myocardial perfusion and late gadolinium enhancement imaging by cardiac magnetic resonance in patients with known or suspected coronary artery disease.. Circulation 2009; 120(14):1390-400.
Bagur R, Bertrand OF, Rodés-Cabau J, Larose E, Rinfret S, Nguyen CM, Noel B, Larochellière RD, Poirier P, Costerousse O, Roy L.. Long term efficacy of abciximab bolus-only compared to abciximab bolus and infusion after transradial coronary stenting.. Catheter Cardiovasc Interv 2009; 74(7):1010-6.
Turmel J, Boulet LP, Sériès F, Poirier P, Tardif JC, Rodés-Cabau J, Larose É, Bertrand OF. Is there an association between coronary atherosclerosis and airway responsiveness?. Acta Cardiol 2008; 63(3):347-53.
Bertrand OF, Rodés-Cabau J, Larose É, Nguyen CM, Roy L, Déry JP, Coutis J, Nault I, Poirier P, Costerousse O, De Larochellière R. One-year clinical outcome after Abciximab bolus-only compared to Abciximab volus and 12h infusion in the randomized Early Discharge After Transradial Stenting of Coronary Arteries (EASY) Study.. Am Heart J 2008; 156(1):135-40.
Rodés-Cabau J, Deblois J, Bertrand OF, Mohammadi S, Courtis J, Larose E, Dagenais F, Déry JP, Mathieu P, Rousseau M, Barbeau G, Baillot R, Gleeton O, Perron J, Nguyen CM, Roy L, Doyle D, De Larochellière R, Bogaty P, Voisine P. Nonrandomized comparison of coronary artery bypass surgery and percutaneous coronary intervention for the treatment of unprotected left main coronary artery disease in octogenarians.. Circulation 2008; 118(23):2374-81.
Lachance P, Déry JP, Rodés-Cabau J, Potvin JM, Barbeau G, Bertrand OF, Gleeton O, Larose E, Nguyen CM, Noël B, Proulx G, Roy L, De Larochellière R. Impact of fractional flow reserve measurement on the clinical management of patients with coronary artery disease evaluated with noninvasive stress tests prior to cardiac catheterization.. Cardiovasc Revasc Med 2008; 9(4):229-34.
Bertrand OF, Rodés-Cabau J, Larose E, Proulx G, Gleeton O, Nguyen CM, Nault I, Roy L, Poirier P, Costerousse O, De Larochellière R. Early and late outcomes in patients excluded from same-day home discharge after transradial stenting and maximal antiplatelet therapy.. Catheter Cardiovasc Interv 2008; 72(5):619-25.
Lachance P, Déry JP, Beaudoin J, Barbeau GE, Noël B, Bertrand OF, Rodés-Cabau J, Nguyen CM, Proulx G, Gleeton O, Larose E, Roy L, Delarochelliére R. ECG-guided immediate intervention at the time of primary PCI to reduce door-to-balloon time in ST-elevation myocardial infarction patients.. J Invasive Cardiol 2008; 20(11):623-6.
Rodés-Cabau J, Noël M, Marrero A, Rivest D, Mackey A, Houde C, Bédard E, Larose E, Verreault S, Peticlerc M, Pibarot P, Bogaty P, Bertrand OF. Atherosclerotic burden findings in young cryptogenic stroke patients with and without a patent foramen ovale.. Stroke 2009; 40(2):419-25.
Turmel J, Sériès F, Boulet LP, Poirier P, Tardif JC, Rodés-Cabeau J, Larose E, Bertrand OF. Relationship between atherosclerosis and the sleep apnea syndrome: an intravascular ultrasound study.. Int J Cardiol 2009; 132(2):203-9.
Bertrand OF, Larose E, Rodés-Cabau J, Gleeton O, Taillon I, Roy L, Poirier P, Costerousse O, De Larochellière RD. Incidence, predictors, and clinical impact of bleeding after transradial coronary stenting and maximal antiplatelet therapy.. Am Heart J 2009; 157(1):164-9.
Larose E, Côté J, Rodés-Cabau J, Noël B, Barbeau G, Bordeleau E, Miró S, Brochu B, Delarochellière R, Bertrand OF. Contrast-enhanced cardiovascular magnetic resonance in the hyperacute phase of ST-elevation myocardial infarction.. Int J Cardiovasc Imaging 2009; 25(5):519-27.
Tizón-Marcos H, Bertrand OF, Rodés-Cabau J, Larose E, Gaudreault V, Bagur R, Gleeton O, Courtis J, Roy L, Poirier P, Costerousse O, De Larochellière R. Impact of female gender and transradial coronary stenting with maximal antiplatelet therapy on bleeding and ischemic outcomes.. Am Heart J 2009; 157(4):740-5.
Courtis J, Rodés-Cabau J, Larose E, Potvin JM, Déry JP, Larochellière RD, Côté M, Cousterousse O, Nguyen CM, Proulx G, Rinfret S, Bertrand OF. Usefulness of coronary fractional flow reserve measurements in guiding clinical decisions in intermediate or equivocal left main coronary stenoses.. Am J Cardiol 2009; 103(7):943-9.
Chow BJ, Larose E, Bilodeau S, Ellins ML, Galiwango P, Kass M, Sheth T, Jassal DS, Kirkpatrick ID, Mancini GB, Mayo J, Abraham A, White J. The 'what, when, where, who and how?' of cardiac computed tomography in 2009: guidelines for the clinician.. Can J Cardiol 2009; 25(3):135-9.
Garcia J, Kadem L, Larose E, Pibarot P. In vivo velocity and flow errors quantification by phase-contrast magnetic resonance imaging.. Conf Proc IEEE Eng Med Biol Soc 2008; 2008(0):1377-80.
Bertrand OF, Larose E, Rodés-Cabau J, Rinfret S, Déry JP, Bagur R, Gleeton O, Nguyen CM, Proulx G, De Larochellière R, Poirier P, Costerousse O, Roy L.. Incidence, range, and clinical effect of hemoglobin changes within 24 hours after transradial coronary stenting.. Am J Cardiol 2010; 106(2):155-61.
Larose E, Behrendt D, Kinlay S, Selwyn AP, Ganz P, Fang JC. Endothelin-1 is a key mediator of coronary vasoconstriction in patients with transplant coronary arteriosclerosis.. Circ Heart Fail 2009; 2(5):409-16.
Rodés-Cabau J, Tardif JC, Cossette M, Bertrand OF, Ibrahim R, Larose E, Grégoire J, L'allier PL, Guertin MC. Acute effects of statin therapy on coronary atherosclerosis following an acute coronary syndrome.. Am J Cardiol 2009; 104(6):750-7.
Bertrand OF, Rodés-Cabau J, Larose E, Nguyen CM, Déry JP, Proulx G, Roy L, Poirier P, Costerousse O, De Larochellière R. Effects of intracoronary compared to intravenous abciximab administration in patients undergoing transradial percutaneous coronary intervention: A sub-analysis of the EASY trial.. Int J Cardiol 2009; 136(2):165-70.
Tizón-Marcos H, De Larochellière R, Larose E. Breakpoint: left main stent fracture--review of the literature.. J Interv Cardiol 2009; 22(4):362-7.
Bagur R, Bertrand OF, Rodés-Cabau J, Rinfret S, Larose E, Tizón-Marcos H, Gleeton O, Nguyen CM, Roy L, Costerousse O, De Larochellière R. Comparison of outcomes in patients > or =70 years versus <70 years after transradial coronary stenting with maximal antiplatelet therapy for acute coronary syndrome.. Am J Cardiol 2009; 104(5):624-9.
Bertrand OF, Rodés-Cabau J, Rinfret S, Larose E, Bagur R, Proulx G, Gleeton O, Costerousse O, De Larochellière R, Roy L. Impact of final activated clotting time after transradial coronary stenting with maximal antiplatelet therapy.. Am J Cardiol 2009; 104(9):1235-40.
Rodés-Cabau J, Bertrand OF, Larose E, Déry JP, Rinfret S, Bagur R, Proulx G, Nguyen CM, Côté M, Landcop MC, Boudreault JR, Rouleau J, Roy L, Gleeton O, Barbeau G, Noël B, Courtis J, Dagenais GR, Després JP, DeLarochellière R. Comparison of plaque sealing with paclitaxel-eluting stents versus medical therapy for the treatment of moderate nonsignificant saphenous vein graft lesions: the moderate vein graft lesion stenting with the taxus stent and intravascular ultrasound (VELETI) pilot trial.. Circulation 2009; 120(20):1978-86.
Larose E, Proulx G, Voisine P, Rodés-Cabau J, De Larochellière R, Rossignol G, Bertrand OF, Tremblay JP. Percutaneous versus surgical delivery of autologous myoblasts after chronic myocardial infarction: an in vivo cardiovascular magnetic resonance study.. Catheter Cardiovasc Interv 2010; 75(1):120-7.
Bagur R, Dumont E, Doyle D, Larose E, Lemieux J, Bergeron S, Bilodeau S, Bertrand OF, De Larochellière R, Rodés-Cabau J. Coronary ostia stenosis after transcatheter aortic valve implantation.. JACC Cardiovasc Interv 2010; 3(2):253-5.
Larose E, Tizon-Marcos H, Rodés-Cabau J, Rinfret S, Déry JP, Nguyen CM, Gleeton O, Boudreault JR, Roy L, Noël B, Proulx G, Rouleau J, Barbeau G, De Larochellière R, Bertrand OF.. Improving myocardial salvage in late presentation acute ST-elevation myocardial infarction with proximal embolic protection.. Catheter Cardiovasc Interv 2010; 76(4):461-70.
Brydie A, Chow BJ, Dennie CJ, Larose E, Leipsic JA, Sheth T. Canadian association of radiologists / canadian cardiovascular society consensus training standards for cardiac computed tomography.. Can Assoc Radiol J 2010; 61(2):68-73.
Brydie A, Chow BJ, Dennie C, Larose E, Leipsic JA, Sheth T (Canadian Cardiovascular Society; Canadian Association of Radiologists). Canadian Cardiovascular Society/Canadian Association of Radiologists consensus training standards for cardiac computed tomography.. Can J Cardiol 2010; 26(4):181-4.
Beaudoin J, Dery JP, Lachance P, Bertrand OF, Larose E, Rodés-Cabau J, Noël B, Barbeau G, Proulx G, Nguyen C, Roy L, Gleeton O, Rinfret S, Delarochellière R. Impact of thrombus aspiration on angiographic and clinical outcomes in patients with ST-elevation myocardial infarction.. Cardiovasc Revasc Med 2010; 11(4):218-22.
Larose E, Rodés-Cabau J, Pibarot P, Rinfret S, Proulx G, Nguyen CM, Déry JP, Gleeton O, Roy L, Noël B, Barbeau G, Rouleau J, Boudreault JR, Amyot M, De Larochellière R, Bertrand OF. Predicting late myocardial recovery and outcomes in the early hours of ST-segment elevation myocardial infarction: Traditional measures compared with microvascular obstruction, salvaged myocardium, and necrosis characteristics by cardiovascular magnetic resonance.. J Am Coll Cardiol 2010; 55(22):2459-69.
Bertrand OF, Rodés-Cabau J, Larose E, Rinfret S, Gaudreault V, Proulx G, Barbeau G, Déry JP, Gleeton O, Manh-Nguyen C, Noël B, Roy L, Costerousse O, De Larochellière R (EArly Discharge after Transradial Stenting of CoronarY Arteries in Acute Myocardial Infarction (EASY-MI) Study Investigators). Intracoronary compared to intravenous Abciximab and high-dose bolus compared to standard dose in patients with ST-segment elevation myocardial infarction undergoing transradial primary percutaneous coronary intervention: a two-by-two factorial placebo-controlled randomized study.. Am J Cardiol 2010; 105(11):1520-7.
Bertrand OF, Philippon F, St Pierre A, Nguyen CM, Larose E, Bilodeau S, Dagenais F, Charbonneau E, Rodés-Cabau J, Sénéchal M. Percutaneous mitral valve annuloplasty for functional mitral regurgitation: acute results of the first patient treated with the Viacor permanent device and future perspectives.. Cardiovasc Revasc Med 2010; 11(4):265.e1-8.
Tizón-Marcos H, Bagur R, Bilodeau S, Larose E, Dagenais F, Déry JP. Left main mycotic aneurysm causing myocardial infarction.. Can J Cardiol 2010; 26(7):e276-7.
Bertrand OF, Rao SV, Pancholy S, Jolly SS, Rodés-Cabau J, Larose E, Costerousse O, Hamon M, Mann T. Transradial approach for coronary angiography and interventions: results of the first international transradial practice survey.. JACC Cardiovasc Interv 2010; 3(10):1022-31.
Bertrand OF, Larose E, Costerousse O, Mongrain R, Rodés-Cabau J, Déry JP, Nguyen CM, Barbeau G, Gleeton O, Proulx G, De Larochellière R, Noël B, Roy L. Effects of aspiration thrombectomy on necrosis size and ejection fraction after transradial percutaneous coronary intervention in acute ST-elevation myocardial infarction.. Catheter Cardiovasc Interv 2011; 77(4):475-82.
Rodés-Cabau J, Dumont E, Boone RH, Larose E, Bagur R, Gurvitch R, Bédard F, Doyle D, De Larochellière R, Jayasuria C, Villeneuve J, Marrero A, Côté M, Pibarot P, Webb JG. Cerebral embolism following transcatheter aortic valve implantation: comparison of transfemoral and transapical approaches.. J Am Coll Cardiol 2011; 57(1):18-28.
Paradis JM, Bertrand OF, Delarochellière R, Déry JP, Larose E, Rodés-Cabau J, Rinfret S, Bélisle P, Joseph L. Response to letter regarding article, "drug-eluting or bare metal stents for the treatment of saphenous vein graft disease: a bayesian meta-analysis".. Circ Cardiovasc Interv 2011; 4(2):e15.
Garcia J, Kadem L, Larose E, Clavel MA, Pibarot P. Comparison between Cardiovascular Magnetic Resonance and Transthoracic Doppler Echocardiography for the Estimation of Effective Orifice Area in Aortic Stenosis.. J Cardiovasc Magn Reson 2011; 13(1):25.
Bagur R, Michaud N, Bergeron S, Rouleau JR, Rodés-Cabau J, Bertrand OF, Larose É. Adult Bland-White-Garland syndrome presenting as cardiomyopathy characterized by subendocardial fibrosis.. J Am Coll Cardiol 2010; 56(8):e15.
Rodés-Cabau J, Gutiérrez M, Bagur R, De Larochellière R, Doyle D, Côté M, Villeneuve J, Bertrand OF, Larose E, Manazzoni J, Pibarot P, Dumont E.. Incidence, predictive factors, and prognostic value of myocardial injury following uncomplicated transcatheter aortic valve implantation.. J Am Coll Cardiol 2011; 57(20):1988-99.
Paradis JM, Bélisle P, Joseph L, Bertrand OF, DeLarochellière R, Déry JP, Larose E, Rodés-Cabau J, Rinfret S.. Drug-eluting or bare metal stents for the treatment of saphenous vein graft disease: a Bayesian meta-analysis.. Circ Cardiovasc Interv 2010; 3(6):565-76.
Rodés-Cabau J, Bertrand OF, Larose E, Déry JP, Rinfret S, Urena M, Jerez M, Nombela-Franco L, Ribeiro HB, Allende R, Proulx G, Nguyen CM, Boudreault JR, Rouleau J, Roy L, Gleeton O, Barbeau G, Noël B, Côté M, Després JP, Dagenais GR, DeLarochellière R. Five-year follow-up of the plaque sealing with paclitaxel-eluting stents vs medical therapy for the treatment of intermediate nonobstructive saphenous vein graft lesions (VELETI) trial.. Can J Cardiol 2014; 30(1):138-45.
Rodés-Cabau J, Gutiérrez M, Courtis J, Larose É, Déry JP, Côté M, Nguyen CM, Gleeton O, Proulx G, Roy L, Noël B, Barbeau G, De Larochellière R, Rinfret S, F Bertrand OF. Importance of Diffuse Atherosclerosis in the Functional Evaluation of Coronary Stenosis in the Proximal-Mid Segment of a Coronary Artery by Myocardial Fractional Flow Reserve Measurements.. Am J Cardiol 2011; 108(4):483-90.
Clavel MA, Rodés-Cabau J, Dumont É, Bagur R, Bergeron S, De Larochellière R, Doyle D, Larose E, Dumesnil JG, Pibarot P. Validation and characterization of transcatheter aortic valve effective orifice area measured by Doppler echocardiography.. JACC Cardiovasc Imaging 2011; 4(10):1053-62.
Arsenault BJ, Beaumont EP, Després JP, Larose E. Mapping body fat distribution: A key step towards the identification of the vulnerable patient?. Ann Med 2012; 44(8):758-72.
Kumar A, Beohar N, Arumana JM, Larose E, Li D, Friedrich MG, Dharmakumar R. CMR imaging of edema in myocardial infarction using cine balanced steady-state free precession.. JACC Cardiovasc Imaging 2011; 4(12):1265-73.
Keshavarz-Motamed Z, Garcia J, Pibarot P, Larose E, Kadem L. Modeling the impact of concomitant aortic stenosis and coarctation of the aorta on left ventricular workload.. J Biomech 2011; 44(16):2817-25.
Rinfret S, Joyal D, Nguyen CM, Bagur R, Hui W, Leung R, Larose E, Love MP, Mansour S. Retrograde recanalization of chronic total occlusions from the transradial approach; early Canadian experience.. Catheter Cardiovasc Interv 2011; 78(3):366-74.
Nombela-Franco L, Rodés-Cabau J, De Larochelliere R, Larose É, Doyle D, Villeneuve J, Bergeron S, Bernier M, Amat-Santos I, Mok M, Urena M, Rheault M, Dumesnil JG, Côté M, Pibarot P, Dumont É. Predictive Factors, Efficacy and Safety of Balloon Post-Dilation following Transcatheter Aortic Valve Implantation with a Balloon-Expandable Valve.. JACC Cardiovasc Interv 2012; 5(5):499-512.
Garcia J, Marrufo OR, Rodriguez AO, Larose E, Pibarot P, Kadem L. Cardiovascular magnetic resonance evaluation of aortic stenosis severity using single plane measurement of effective orifice area.. J Cardiovasc Magn Reson 2012; 14(1):23.
Bataille Y, Déry JP, Larose E, Abdelaal E, Machaalany J, Rodés-Cabau J, Rinfret S, Déry U, Costerousse O, Roy L, Bertrand OF. Incidence and clinical impact of concurrent chronic total occlusion according to gender in ST-Elevation myocardial infarction.. Catheter Cardiovasc Interv 2013; 82(1):19-26.
Bataille Y, Déry JP, Larose É, Déry U, Costerousse O, Rodés-Cabau J, Gleeton O, Proulx G, Abdelaal E, Machaalany J, Nguyen CM, Noël B, Bertrand OF. Deadly association of cardiogenic shock and chronic total occlusion in acute ST-elevation myocardial infarction.. Am Heart J 2012; 164(4):509-15.
Urena M, Mok M, Serra V, Dumont E, Nombela-Franco L, De Larochellière R, Doyle D, Igual A, Larose E, Amat-Santos I, Côté M, Cuéllar H, Pibarot P, de Jaegere P, Philippon F, Garcia del Blanco B, Rodés-Cabau J. Predictive factors and long-term clinical consequences of persistent left bundle branch block following transcatheter aortic valve implantation with a balloon-expandable valve.. J Am Coll Cardiol 2012; 60(18):1743-52.
MacHaalany J, Abdelaal E, Bataille Y, Plourde G, Duranleau-Gagnon P, Larose É, Déry JP, Barbeau G, Rinfret S, Rodés-Cabau J, De Larochellière R, Roy L, Costerousse O, Bertrand OF. Benefit of bivalirudin versus heparin after transradial and transfemoral percutaneous coronary intervention.. Am J Cardiol 2012; 110(12):1742-8.
Bataille Y, Déry JP, Larose E, Déry U, Costerousse O, Rodés-Cabau J, Rinfret S, De Larochellière R, Abdelaal E, Machaalany J, Barbeau G, Roy L, Bertrand OF. Prevalence, predictors and clinical impact of unique and multiple chronic total occlusion in non-infarct-related artery in patients presenting with ST-elevation myocardial infarction.. Heart 2012; 98(23):1732-7.
FREEDOM Trial Investigators (incluant Métras J, Larose É, Baillot R, Barbeau G, Bertrand OF, Déry JP, Doyle, Gleeton O, Nguyen CM, Noël B, Proulx G, Raby K, Rinfret S et Roy L du CRIUCPQ). Strategies for multivessel revascularization in patients with diabetes. N Engl J Med 2012; 367(25):2375-84.
Abdelaal E, Plourde G, Machaalany J, Arsenault J, Rimac G, Déry JP, Barbeau G, Larose E, De Larochellière R, Nguyen CM, Allende R, Ribeiro H, Costerousse O, Mongrain R, Bertrand OF. Effectiveness of Low Rate Fluoroscopy at Reducing Operator and Patient Radiation Dose During Transradial Coronary Angiography and Interventions.. JACC Cardiovasc Interv 2014; 7(5):567-74.
Capoulade R, Larose E, Mathieu P, Clavel MA, Dahou A, Arsenault M, Bédard E, Larue-Grondin S, Le Ven F, Dumesnil JG, Després JP, Pibarot P.. Visceral adiposity and left ventricular mass and function in patients with aortic stenosis: The PROGRESSA Study.. Can J Cardiol 2014; 30(9):1080-7.
Machaalany J, St-Pierre A, Sénéchal M, Larose E, Philippon F, Abdelaal E, Charbonneau E, Dagenais F, Trahan S, Bertrand OF. Fatal late migration of viacor percutaneous transvenous mitral annuloplasty device resulting in distal coronary venous perforation.. Can J Cardiol 2013; 29(1):130.e1-4.
Mahjoub H, Mathieu P, Sénéchal M, Larose E, Dumesnil J, Després JP, Pibarot P. ApoB/ApoA-I ratio is associated with increased risk of bioprosthetic valve degeneration.. J Am Coll Cardiol 2013; 61(7):752-61.
Pibarot P, Larose E, Dumesnil J. Imaging of valvular heart disease.. Can J Cardiol 2013; 29(3):337-49.
Exner DV, Birnie DH, Moe G, Thibault B, Philippon F, Healey JS, Tang AS, Larose É, Parkash R. Canadian Cardiovascular Society guidelines on the use of cardiac resynchronization therapy: evidence and patient selection.. Can J Cardiol 2013; 29(2):182-95.
Garcia J, Pibarot P, Capoulade R, Le Ven F, Kadem L, Larose E. Usefulness of cardiovascular magnetic resonance imaging for the evaluation of valve opening and closing kinetics in aortic stenosis.. Eur Heart J Cardiovasc Imaging 2013; 14(8):819-26.
Forcillo J, Stevens LM, Mansour S, Prieto I, Salem R, Baron C, Roy DC, Larose E, Masckauchan D, Noiseux N. Implantation of CD133(+) Stem Cells in Patients Undergoing Coronary Bypass Surgery: IMPACT-CABG Pilot Trial.. Can J Cardiol 2013; 29(4):441-7.
Friedrich MG, Larose E, Patton D, Dick A, Merchant N, Paterson I. Canadian Society for Cardiovascular Magnetic Resonance (CanSCMR) Recommendations for Cardiovascular Magnetic Resonance Image Analysis and Reporting.. Can J Cardiol 2013; 29(3):260-5.
Plourde G, Abdelaal E, Bataille Y, Machaalany J, Déry JP, Déry U, Larose E, De Larochellière R, Gleeton O, Barbeau G, Roy L, Costerousse O, Bertrand OF. Effect on Door-to-Balloon Time of Immediate Transradial Percutaneous Coronary Intervention on Culprit Lesion in ST-Elevation Myocardial Infarction Compared to Diagnostic Angiography Followed by Primary Percutaneous Coronary Intervention.. Am J Cardiol 2013; 111(6):836-40.
Rinfret S, Rodés-Cabau J, Bagur R, Déry JP, Dorais M, Larose E, Barbeau G, Gleeton O, Nguyen CM, Noël B, Proulx G, Roy L, Taillon I, De Larochellière R, Bertrand OF. Telephone contact to improve adherence to dual antiplatelet therapy after drug-eluting stent implantation.. Heart 2013; 99(8):562-9.
Abdelaal E, Molin P, Plourde G, Machaalany J, Bataille Y, Brousseau-Provencher C, Montminy S, Larose E, Roy L, Gleeton O, Barbeau G, Nguyen CM, Noël B, Costerousse O, Bertrand OF. Successive transradial access for coronary procedures: Experience of Quebec Heart-Lung Institute.. Am Heart J 2013; 165(3):325-31.
MacHaalany J, Bertrand OF, O'Connor K, Abdelaal E, Voisine P, Larose É, Charbonneau É, Costerousse O, Déry JP, Sénéchal M. Predictors and prognosis of early ischemic mitral regurgitation in the era of primary percutaneous coronary revascularisation.. Cardiovasc Ultrasound 2014; 12(0):14.
Noiseux N, Stevens LM, Prieto I, Salem R, Roy DC, Larose E, Mansour S.. Reply to Letter From Kopjar et al.-The IMPACT-CABG Pilot Trial.. Can J Cardiol 2013; 29(11):1533.e3.
O Meara E, Mielniczuk LM, Wells GA, Dekemp RA, Klein R, Coyle D, Mc Ardle B, Paterson I, White JA, Arnold M, Friedrich MG, Larose E, Dick A, Chow B, Dennie C, Haddad H, Ruddy T, Ukkonen H, Wisenberg G, Cantin B, Pibarot P, Freeman M, Turcotte E, Connelly K, Clarke J, Williams K, Racine N, Garrard L, Tardif JC, Dasilva J, Knuuti J, Beanlands R.. Alternative Imaging Modalities in Ischemic Heart Failure (AIMI-HF) IMAGE HF Project I-A: study protocol for a randomized controlled trial.. Trials 2013; 14(1):218.
Bataille Y, Plourde G, Machaalany J, Abdelaal E, Déry JP, Larose E, Déry U, Noël B, Barbeau G, Roy L, Costerousse O, Bertrand OF.. Interaction of Chronic Total Occlusion and Chronic Kidney Disease in Patients Undergoing Primary Percutaneous Coronary Intervention for Acute ST-Elevation Myocardial Infarction.. Am J Cardiol 2013; 112(2):194-9.
Binder RK, Webb JG, Willson AB, Urena M, Hansson NC, Norgaard BL, Pibarot P, Barbanti M, Larose E, Freeman M, Dumont E, Thompson C, Wheeler M, Moss RR, Yang TH, Pasian S, Hague C, Nguyen G, Raju R, Toggweiler S, Min JK, Wood DA, Rodés-Cabau J, Leipsic J.. The Impact of Integration of a Multidetector Computed Tomography Annulus Area Sizing Algorithm on Outcomes of Transcatheter Aortic Valve Replacement: A Prospective, Multicenter, Controlled Trial.. J Am Coll Cardiol 2013; 62(5):431-8.
Ribeiro HB, Webb JG, Makkar RR, Cohen MG, Kapadia S, Kodali S, Tamburino C, Barbanti M, Chakravarty T, Jilaihawi H, Paradis JM, de Brito FS Jr, Cánovas SJ, Cheema AN, de Jaegere P, Valle RD, Chiam PT, Moreno R, Pradas G, Ruel M, Salgado-Fernández J, Sarmento-Leite R, Toeg H, Velianou JL, Zajarias A, Babaliaros V, Cura F, Dager AE, Manoharan G, Lerakis S, Pichard A, Radhakrishnan S, Perin MA, Dumont E, Larose E, Pasian SG, Nombela-Franco L, Urena M, Tuzcu EM, Leon MB, Amat-Santos IJ, Leipsic J, Rodés-Cabau J.. Predictive Factors, Management and Clinical Outcomes of Coronary Obstruction Following Transcatheter Aortic Valve Implantation: Insights from a Large Multicenter Registry.. J Am Coll Cardiol 2013; 62(17):1552-62.
Garcia J, Capoulade R, Le Ven F, Gaillard E, Kadem L, Pibarot P, Larose E.. Discrepancies between cardiovascular magnetic resonance and Doppler echocardiography in the measurement of transvalvular gradient in aortic stenosis: the effect of flow vorticity.. J Cardiovasc Magn Reson 2013; 15(1):84.
Garcia J, Larose E, Pibarot P, Kadem L. On the Evaluation of Vorticity using Cardiovascular Magnetic Resonance Velocity Measurements.. J Biochem Eng 2013; 135(12):124501-6.
De Larochellière E, Côté J, Gilbert G, Bibeau K, Ross MK, Dion-Roy V, Pibarot P, Després JP, Larose E. Visceral/epicardial adiposity in nonobese and apparently healthy young adults: Association with the cardiometabolic profile.. Atherosclerosis 2014; 234(1):23-9.
Nombela-Franco L, Ribeiro HB, Urena M, Pasian S, Allende R, Doyle D, Delarochellière R, Delarochellière H, Laflamme L, Laflamme J, Jerez-Valero M, Côté M, Pibarot P, Larose E, Dumont E, Rodés-Cabau J.. Incidence, predictive factors and haemodynamic consequences of acute stent recoil following transcatheter aortic valve implantation with a balloon-expandable valve.. EuroIntervention 2014; 9(12):1398-406.
Paterson I, Wells GA, Ezekowitz JA, White JA, Friedrich MG, Mielniczuk LM, O Meara E, Chow B, Dekemp RA, Klein R, Dennie C, Dick A, Coyle D, Dwivedi G, Rajda M, Wright GA, Laine M, Hanninen H, Larose E, Connelly KA, Leong-Poi H, Howarth A, Davies RA, Duchesne L, Yla-Herttuala S, Saraste A, Farand P, Garrard L, Tardif JC, Arnold M, Knuuti J, Beanlands R, Chan KL.. Routine versus selective cardiac magnetic resonance in non-ischemic heart failure -- OUTSMART-HF: study protocol for a randomized controlled trial (IMAGE-HF (heart failure) project 1-B).. Trials 2013; 14(1):332.
Clavel MA, Messika-Zeitoun D, Pibarot P, Aggarval S, Malouf J, Araoz P, Michelina H, Cueff C, Larose É, Capoulade R, Vahanian A, Enriquez-Sarano M. The complex nature of discordant aortic stenosis severity grading: New insights from combined Doppler-Echocardiographic and computed tomography study.. J Am Coll Cardiol 2013; 62(24):2329-38.
Gaudreault V, Tizon-Marcos H, Poirier P, Pibarot P, Gilbert P, Amyot M, Rodés-Cabau J, Després JP, Bertrand OF, Larose É.. Transient Myocardial Tissue and Function Changes During a Marathon in Less Fit Marathon Runners.. Can J Cardiol 2013; 29(10):1269-76.
Arsenault BJ, Larose E.. Appreciating the local and systemic effects of exercise training on vascular health.. Atherosclerosis 2013; 231(1):15-7.
Chow BJ, Green RE, Coyle D, Laine M, Hanninen H, Leskinen H, Rajda M, Larose E, Hartikainen J, Hedman M, Mielniczuk L, O'Meara E, deKemp RA, Klein R, Paterson I, White JA, Yla-Herttuala S, Leber A, Tandon V, Lee T, Al-Hesayen A, Hessian R, Dowsley T, Kass M, Kelly C, Garrard L, Tardif JC, Knuuti J, Beanlands RS, Wells GA. Computed tomographic coronary angiography for patients with heart failure (CTA-HF): a randomized controlled trial (IMAGE HF Project 1-C).. Trials 2013; 14(0):443.
Kohen Avramoglu R, Laplante MA, Le Quang K, Deshaies Y, Després JP, Larose E, Mathieu P, Poirier P, Pérusse L, Vohl MC, Sweeney G, Ylä-Herttuala S, Laakso M, Uusitupa M, Marette A. The genetic and metabolic determinants of cardiovascular complications in type 2 diabetes: recent insights from animal models and clinical investigations.. Can J Diabetes 2013; 37(5):351-8.
Abdelaal E, Brousseau-Provencher C, Montminy S, Plourde G, MacHaalany J, Bataille Y, Molin P, Déry JP, Barbeau G, Roy L, Larose É, De Larochellière R, Nguyen CM, Proulx G, Costerousse O, Bertrand OF. Risk score, causes, and clinical impact of failure of transradial approach for percutaneous coronary interventions.. JACC Cardiovasc Interv 2013; 6(11):1129-37.
Parkash R, Philippon F, Shanks M, Thibault B, Cox J, Low A, Essebag V, Bashir J, Moe G, Birnie DH, Larose E, Yee R, Swiggum E, Kaul P, Redfearn D, Tang AS, Exner DV.. Canadian cardiovascular society guidelines on the use of cardiac resynchronization therapy: implementation.. Can J Cardiol 2013; 29(11):1346-60.
Mahjoub H, Mathieu P, Larose É, Dahou A, Sénéchal M, Dumesnil JG, Després JP, Pibarot P. Determinants of aortic bioprosthetic valve calcification assessed by multidetector CT.. Heart 2015; 101(6):472-7.
Capoulade R, Mahmut A, Tastet L, Arsenault M, Bédard É, Dumesnil JG, Després JP, Larose É, Arsenault BJ, Bossé Y, Mathieu P, Pibarot P. Impact of Plasma Lp-PLA2 Activity on the Progression of Aortic Stenosis: The PROGRESSA Study.. JACC Cardiovasc Imaging 2015; 8(1):26-33.
Tizón-Marcos H, de la Paz Ricapito M, Pibarot P, Bertrand OF, Bibeau K, Le Ven F, Sinha S, Engert J, Bédard E, Pasian S, Deschepper C, Larose É. Characteristics of trabeculated myocardium burden in young and apparently healthy adults.. Am J Cardiol 2014; 114(7):1094-9.
Amat-Santos IJ, Dahou A, Webb J, Dvir D, Dumesnil JG, Allende R, Ribeiro HB, Urena M, Paradis JM, DeLarochellière R, Dumont E, Bergeron S, Thompson CR, Pasian S, Bilodeau S, Leipsic J, Larose E, Pibarot P, Rodés-Cabau J.. Comparison of hemodynamic performance of the balloon-expandable SAPIEN 3 versus SAPIEN XT transcatheter valve.. Am J Cardiol 2014; 114(7):1075-82.
Kumar A, Bagur R, Béliveau P, Potvin JM, Levesque P, Fillion N, Tremblay B, Larose É, Gaudreault V. Acute myocarditis triggering coronary spasm and mimicking acute myocardial infarction.. World J Cardiol 2014; 6(9):1045-8.
Laflamme MH, Mahjoub H, Mahmut A, Boulanger MC, Larose E, Pibarot P, Mathieu P. Parathyroid hormone is associated with the LV mass after aortic valve replacement.. Heart 2014; 100(23):1859-64.
Ribeiro HB, Le Ven F, Larose É, Dahou A, Nombela-Franco L, Urena M, Allende R, Amat-Santos I, Ricapito Mde L, Thébault C, Clavel MA, Delarochelliére R, Doyle D, Dumont É, Dumesnil JG1, Pibarot P1, Rodés-Cabau J1. Cardiac magnetic resonance versus transthoracic echocardiography for the assessment and quantification of aortic regurgitation in patients undergoing transcatheter aortic valve implantation.. Heart 2014; 100(24):1924-32.
Friedrich MG, Bucciarelli-Ducci C, White JA, Plein S, Moon JC, Almeida AG, Kramer CM, Neubauer S, Pennell DJ, Petersen SE, Kwong RY, Ferrari VA, Schulz-Menger J, Sakuma H, Schelbert EB, Larose É, Eitel I, Carbone I, Taylor AJ, Young A, de Roos A, Nagel E.. Simplifying cardiovascular magnetic resonance pulse sequence terminology.. J Cardiovasc Magn Reson 2014; 16(0):3960.
Garcia J, Keshavarz-Motamed Z, Capoulade R, Le Ven F, Kadem L, Larose E, Pibarot P.. Normalized left ventricular workload using phase-contrast magnetic resonance imaging in patients with aortic stenosis.. Conf Proc IEEE Eng Med Biol Soc 2014; 2014(0):6430-3.
Clavel MA, Pibarot P, Messika-Zeitoun D, Capoulade R, Malouf J, Aggarval S, Araoz PA, Michelena HI, Cueff C, Larose E, Miller JD, Vahanian A, Enriquez-Sarano M. Impact of aortic valve calcification, as measured by MDCT, on survival in patients with aortic stenosis: results of an international registry study.. J Am Coll Cardiol 2014; 64(12):1202-13.
Le Ven F, Tizón-Marcos H, Fuchs C, Mathieu P, Pibarot P, Larose E. Valve tissue characterization by magnetic resonance imaging in calcific aortic valve disease.. Can J Cardiol 2014; 30(12):1676-83.
Dahou A, Magne J, Clavel MA, Capoulade R, Bartko PE, Bergler-Klein J, Sénéchal M, Mundigler G, Burwash I, Ribeiro HB, O'Connor K, Mathieu P, Baumgartner H, Dumesnil JG, Rosenhek R, Larose É, Rodés-Cabau J, Pibarot P. Tricuspid Regurgitation Is Associated With Increased Risk of Mortality in Patients With Low-Flow Low-Gradient Aortic Stenosis and Reduced Ejection Fraction: Results of the Multicenter TOPAS Study (True or Pseudo-Severe Aortic Stenosis).. JACC Cardiovasc Interv 2015; 8(4):588-96.
Ribeiro HB, Larose É, de la Paz Ricapito M, Le Ven F, Nombela-Franco L, Urena M, Allende R, Amat-Santos I, Dahou A, Capoulade R, Clavel MA, Mohammadi S, Paradis JM, De Larochellière R, Doyle D, Dumont É, Pibarot P, Rodés-Cabau J. Myocardial injury following transcatheter aortic valve implantation: insights from delayed-enhancement cardiovascular magnetic resonance.. EuroIntervention 2015; 11(2):205-13.
Le Ven F, Bibeau K, De Larochellière É, Tizón-Marcos H, Deneault-Bissonnette S, Pibarot P, Deschepper CF, Larose É. Cardiac morphology and function reference values derived from a large subset of healthy young Caucasian adults by magnetic resonance imaging.. Eur Heart J Cardiovasc Imaging 2015; 0(0):Epub.
Larose É. Guilty as Sin: Revisiting Sutton's Law in ST-Segment Elevation Myocardial Infarction.. J Am Coll Cardiol 2015; 66(24):2725-7.
Harvey A, Modak A, Déry U, Roy M, Rinfret S, Bertrand OF, Larose É, Rodés-Cabau J, Barbeau G, Gleeton O, Nguyen CM, Proulx G, Noël B, Roy L, Paradis JM, De Larochellière R, Déry JP. Changes in CYP2C19 enzyme activity evaluated by the [(13)C]-pantoprazole breath test after co-administration of clopidogrel and proton pump inhibitors following percutaneous coronary intervention and correlation to platelet reactivity.. J Breath Res 2016; 10(1):017104.
Tastet L, Capoulade R, Clavel MA, Larose É, Shen M, Dahou A, Arsenault M, Mathieu P, Bédard É, Dumesnil JG, Tremblay A, Bossé Y, Després JP, Pibarot P. Systolic hypertension and progression of aortic valve calcification in patients with aortic stenosis: results from the PROGRESSA study.. Eur Heart J Cardiovasc Imaging 2017; 18(1):70-78.
Mahmut A, Mahjoub H, Boulanger MC, Dahou A, Bouchareb R, Capoulade R, Arsenault BJ, Larose E, Bossé Y, Pibarot P, Mathieu P. Circulating Lp-PLA2 is associated with high valvuloarterial impedance and low arterial compliance in patients with aortic valve bioprostheses.. Clin Chim Acta 2016; 455(0):20-5.
Dahou A, Clavel MA, Capoulade R, Bartko PE, Magne J, Mundigler G, Bergler-Klein J, Burwash I, Mascherbauer J, Ribeiro HB, O'Connor K, Baumgartner H, Sénéchal M, Dumesnil JG, Rosenhek R, Mathieu P, Larose E, Rodés-Cabau J, Pibarot P. Right ventricular longitudinal strain for risk stratification in low-flow, low-gradient aortic stenosis with low ejection fraction.. Heart 2016; 102(7):548-54.
Sénéchal M, Bernard PL, Cloutier S, Leblanc MH, Larose É, Cinq-Mars A, Dubois M. Management of Loeffler's Endocarditis With Bivalvular Involvement and a FIP1L1/PDGFRA-Negative Mutation.. Can J Cardiol 2016; 32(12):1577.
Abdelaal E, MacHaalany J, Plourde G, Barria Perez A, Bouchard MP, Roy M, Déry JP, Déry U, Barbeau G, Larose É, Gleeton O, Noël B, Rodés-Cabau J, Roy L, Costerousse O, Bertrand OF. Prediction and impact of failure of transradial approach for primary percutaneous coronary intervention.. Heart 2016; 102(12):919-25.
Douglas PS, Hoffmann U, Patel MR, Mark DB, Al-Khalidi HR, Cavanaugh B, Cole J, Dolor RJ, Fordyce CB, Huang M, Khan MA, Kosinski AS, Krucoff MW, Malhotra V, Picard MH, Udelson JE, Velazquez EJ, Yow E, Cooper LS, Lee KL; PROMISE Investigators (Collaborateurs: Carlos E, Cole J, Johnson M, Krista M, Ridner M, Abidov A, Barker B, Bies R, Jones D, Weathers L, Albert T, Ariani K, Banerjee S, Budoff M, Chang D, Forman S, Foster G, Hsu J, Jang J, Kahn A, Karlsberg R, Krishnam M, Lee M, Lepor N, Loh I, Lurie M, McConnell M, Ruehm S, Vorobiof G, Abramson S, Friedrich S, Moloo J, Treat S, Keller A, Yang C, Bramlet D, Braun E, Foucauld J, Ghai A, Guzman P, Hendel R, Javier J, Schmalfuss C, Schneider R, Sotolongo C, Tannenbaum A, Weinstock B, Champney K, Frohwein S, Jenkins L, Koganti D, Litwin S, Shapiro P, Leung C, Hinchman D, Clark S, Danciu S, Hines J, Patel A, Sullivan D, Trivedi D, Vidovich M, Mahenthiran J, Shaikh S, Teague S, Clark C, Martin E, Sigurdsson G, Bloom S, Hagley M, Schmidt W 2nd, Sorrell V, Turner M, Weiss R, Hearne S, Jerome S, Morss A, Ruberg R, Truong Q, Abdul-Nour K, Chinnaiyan K, Goraya T, Heath J, Meengs M, Nahhas G, Nounou M, Saba S, Sallach S, Ginete W, Helmer G, McLaurin M, Pellikka P, Pelzel J, Carroll W, Martin A, Rivard A, Ciaramita J, Hawa Z, Woodard P, Jehle A, Delcore M, Porter T, Van De Graaff E, Budhwani N, Bullock-Palmer R, Espinoza A, Kostis J, Mustafa M, Cavanaugh B, Cohen R, Donnino R, Garcia M, Goodman D, Heitner J, Kamran M, Lader E, Marmulstein M, Menzies D, Morris R, Page B, Park C, Poon M, Wilson M, Atieh M, Bohle D, Dolor R, Dulin M, Gring C, Hakas J, McLean D, Rorie M, Sharkey K, Almanaseer Y, Dirkes W, Goldberg J, Iler M, Kutoloski K, Maaieh M, Mashny J, Pelberg R, Richards D, Tinkel J, Chrysant G, Des Prez R, Hill G, Hussain I, Shapiro M, Allen C, Babayan Z, Bauch T, Berliner J, Bove A, Fox D, Jacob R, Jamis-Dow C, Nadar V, Phiambolis T, Gregg D, Isbell D, Johnson S, Kumar P, Hiremagalur S, Huneycutt D Jr, Korban E, Severance H, Banerjee S, Baweja G, Erwin J 3rd, Gigliotti O, Khan M, Lieber I, Navetta F, Osborne J, Slim A, Wilks R, George A, Hartman A, Levitt R, Phillips C, Salerno M, Schietinger B, Slowikowski J, Malhotra V, Waggoner L, Carter W, Liberman J, Logemann T, Manley J, Port S, Zasadil M, Chow B, Larose E, Tardif JC). Outcomes of anatomical versus functional testing for coronary artery disease.. N Engl J Med 2015; 372(14):1291-300.
Dahou A, Toubal O, Clavel MA, Beaudoin J, Magne J, Mathieu P, Philippon F, Dumesnil JG, Puri R, Ribeiro HB, Larose É, Rodés-Cabau J, Pibarot P. Relationship Between QT Interval and Outcome in Low-Flow Low-Gradient Aortic Stenosis With Low Left Ventricular Ejection Fraction.. J Am Heart Assoc 2016; 5(10):e003980.
Nsaibia MJ, Mahmut A, Mahjoub H, Dahou A, Bouchareb R, Boulanger MC, Després JP, Bossé Y, Arsenault BJ, Larose E, Pibarot P, Mathieu P. Association between plasma lipoprotein levels and bioprosthetic valve structural degeneration.. Heart 2016; 102(23):1915-1921.
Ribeiro HB, Orwat S, Hayek SS, Larose É, Babaliaros V, Dahou A, Le Ven F, Pasian S, Puri R, Abdul-Jawad Altisent O, Campelo-Parada F, Clavel MA, Pibarot P, Lerakis S, Baumgartner H, Rodés-Cabau J. Cardiovascular Magnetic Resonance to Evaluate Aortic Regurgitation After Transcatheter Aortic Valve Replacement.. J Am Coll Cardiol 2016; 68(6):577-85.
Boyer M, Lévesque V, Poirier P, Marette A, Mathieu P, Després JP, Larose É, Arsenault BJ. Impact of a 1-year lifestyle modification program on plasma lipoprotein and PCSK9 concentrations in patients with coronary artery disease.. J Clin Lipidol 2016; 10(6):1353-1361.
Anand SS, Tu JV, Awadalla P, Black S, Boileau C, Busseuil D, Desai D, Després JP, de Souza RJ, Dummer T, Jacquemont S, Knoppers B, Larose E, Lear SA, Marcotte F, Moody AR, Parker L, Poirier P, Robson PJ, Smith EE, Spinelli JJ, Tardif JC, Teo KK, Tusevljak N, Friedrich MG. Rationale, design, and methods for Canadian alliance for healthy hearts and minds cohort study (CAHHM) - a Pan Canadian cohort study.. BMC Public Health 2016; 16(0):650.
Noiseux N, Mansour S, Weisel R, Stevens LM, Der Sarkissian S, Tsang K, Crean AM, Larose E, Li SH, Wintersperger B, Vu MQ, Prieto I, Li RK, Roy DC, Yau TM. The IMPACT-CABG trial: A multicenter, randomized clinical trial of CD133⁺ stem cell therapy during coronary artery bypass grafting for ischemic cardiomyopathy.. J Thorac Cardiovasc Surg 2016; 152(6):1582-1588.e2.
Cavalcante JL, Larose E. Intravascular MRI for Plaque Characterization: Are We Close to Reality?. Curr Cardiol Rep 2016; 18(9):89.
Le Ven F, Bibeau K, De Larochellière É, Tizón-Marcos H, Deneault-Bissonnette S, Pibarot P, Deschepper CF, Larose É. Cardiac morphology and function reference values derived from a large subset of healthy young Caucasian adults by magnetic resonance imaging.. Eur Heart J Cardiovasc Imaging 2016; 17(9):981-90.
Shen M, Tastet L, Capoulade R, Larose É, Bédard É, Arsenault M, Chetaille P, Dumesnil JG, Mathieu P, Clavel MA, Pibarot P. Effect of age and aortic valve anatomy on calcification and haemodynamic severity of aortic stenosis.. Heart 2017; 103(1):32-39.
Dahou A, Clavel MA, Dumesnil JG, Capoulade R, Ribeiro HB, O'Connor K, Mathieu P, Beaudoin J, Larose É, Rodés-Cabau J, Pibarot P. Impact of AVR on LV Remodeling and Function in Paradoxical Low-Flow, Low-Gradient Aortic Stenosis With Preserved LVEF.. JACC Cardiovasc Imaging 2017; 10(1):88-89.
Poirier P, Marette A, Després JP, Larose E, Arsenault BJ.. Mortality in the Familial Atherosclerosis Treatment Study-Observational Study.. J Clin Lipidol 2017; 11(1):309-10.
Tastet L, Enriquez-Sarano M, Capoulade R, Malouf J, Araoz PA, Shen M, Michelena HI, Larose E, Arsenault M, Bédard É, Pibarot P, Clavel MA. Impact of Aortic Valve Calcification and Sex on Hemodynamic Progression and Clinical Outcomes in AS.. J Am Coll Cardiol 2017; 69(16):2096-2098.
LeBlanc S, Bibeau K, Bertrand OF, Lévesque V, Deschênes St-Pierre B, Pibarot P, Després JP, Larose E.. Carotid versus coronary atherosclerosis burdens in acute compared with chronic symptomatic coronary artery disease.. Can J Physiol Pharmacol 2017; 95(8):878-87.
Hage A, Voisine P, Erthal F, Larose E, Glineur D, Chow B, Tremblay H, Fortier J, Ko G, Une D, Farkouh M, Mesana TG, LeMay M, Kulik A, Ruel M. Eight-year follow-up of the Clopidogrel After Surgery for Coronary Artery Disease (CASCADE) trial.. J Thorac Cardiovasc Surg 2018; 155(1):212-222.e2.
Capoulade R, Teoh JG, Bartko PE, Teo E, Scholtz JE, Tastet L, Shen M, Mihos CG, Park YH, Garcia J, Larose E, Isselbacher EM, Sundt TM, MacGillivray TE, Melnitchouk S, Ghoshhajra BB, Pibarot P, Hung J. Relationship Between Proximal Aorta Morphology and Progression Rate of Aortic Stenosis.. J Am Soc Echocardiogr 2018; 31(5):561-9.e1.
Maes F, Costerousse O, Cieza T, Henry M, Déry JP, Barbeau G, De Larochellière R, Paradis JM, Larose E, Nguyen CM, Pirlet C, Mongrain R, Bertrand OF. Transradial experience with bioresorbable vascular scaffolds: A case-matched study with metallic drug-eluting stents.. Cardiovasc Revasc Med 2018; 19(6):700-704.
LeBlanc S, Coulombe F, Bertrand OF, Bibeau K, Pibarot P, Marette A, Alméras N, Lemieux I, Després JP, Larose E.. Hypertriglyceridemic Waist: A Simple Marker of High-Risk Atherosclerosis Features Associated With Excess Visceral Adiposity/Ectopic Fat.. J Am Heart Assoc 2018; 7(8):e008139.
Annabi MS, Touboul E, Dahou A, Burwash IG, Bergler-Klein J, Enriquez-Sarano M, Orwat S, Baumgartner H, Mascherbauer J, Mundigler G, Cavalcante JL, Larose E, Pibarot P, Clavel MA. Dobutamine Stress Echocardiography for Management of Low-Flow, Low-Gradient Aortic Stenosis.. J Am Coll Cardiol 2018; 71(5):475-485.
Frigault J, Lafrenière-Bessi V, Perron J, Bédard É, Philippon F, Poirier P, Larose E, Jacques F. Anomalous Left Coronary Artery from the Pulmonary Artery: Masquerading as Peripartum Cardiomyopathy.. Ann Thorac Surg 2018; 106(1):e33-e35.
Bertrand OF, Larose E, Bagur R, Maes F, Gaudreault V, Noël B, Barbeau G, Déry JP, Pirlet C, Costerousse O; Early Discharge After Transradial Stenting of Coronary Arteries in Acute Myocardial Infarction (EASY-RESCUE) Percutaneous Coronary Intervention (PCI) Study Investigators2.. A Randomized Double-Blind Placebo-Controlled Study Comparing Intracoronary Versus Intravenous Abciximab in Patients With ST-Elevation Myocardial Infarction Undergoing Transradial Rescue Percutaneous Coronary Intervention After Failed Thrombolysis.. Am J Cardiol 2018; 122(1):47-53.
Everett RJ, Tastet L, Clavel MA, Chin CWL, Capoulade R, Vassiliou VS, Kwiecinski J, Gomez M, van Beek EJR, White AC, Prasad SK, Larose E, Tuck C, Semple S, Newby DE, Pibarot P, Dweck MR. Progression of Hypertrophy and Myocardial Fibrosis in Aortic Stenosis: A Multicenter Cardiac Magnetic Resonance Study.. Circ Cardiovasc Imaging 2018; 11(6):e007451.
Coats V, Després JP, Alméras N, Martin M, Sin DD, Rabasa-Lhoret R, Larose E, Tan WC, Bourbeau J, Maltais F. Ectopic adiposity and cardiometabolic health in COPD.. Int J Chron Obstruct Pulmon Dis 2018; 13(0):3331-3340.
Shen M, Capoulade R, Tastet L, Guzzetti E, Clavel MA, Salaun E, Bédard É, Arsenault M, Chetaille P, Tizón-Marcos H, Le Ven F, Pibarot P, Larose E.. Prevalence of left ventricle non-compaction criteria in adult patients with bicuspid aortic valve versus healthy control subjects.. Open Heart 2018; 5(2):e000869.
Boyer M, Lévesque V, Poirier P, Marette A, Mitchell PL, Mora S, Mathieu P, Després JP, Larose E, Arsenault BJ. Longitudinal Changes in Cholesterol Efflux Capacities in Patients With Coronary Artery Disease Undergoing Lifestyle Modification Therapy.. J Am Heart Assoc 2018; 7(11):e008681.
Salaun E, Mahjoub H, Dahou A, Mathieu P, Larose E, Després JP, Rodés-Cabau J, Arsenault BJ, Puri R, Clavel MA, Pibarot P. Hemodynamic Deterioration of Surgically Implanted Bioprosthetic Aortic Valves.. J Am Coll Cardiol 2018; 72(3):241-251.
Neubauer S, Kolm P, Ho CY, Kwong RY, Desai MY, Dolman SF, Appelbaum E, Desvigne-Nickens P, DiMarco JP, Friedrich MG, Geller N, Harper AR, Jarolim P, Jerosch-Herold M, Kim DY, Maron MS, Schulz-Menger J, Piechnik SK, Thomson K, Zhang C, Watkins H, Weintraub WS, Kramer CM; HCMR Investigators )Larose E parmi les 38 collaborateurs). Distinct Subgroups in Hypertrophic Cardiomyopathy in the NHLBI HCM Registry.. J Am Coll Cardiol 2019; 74(19):2333-2345.
Piché ME, Poirier P, Marette A, Mathieu P, Lévesque V, Bibeau K, Larose E, Després JP. Benefits of 1-Year Lifestyle Modification Program on Exercise Capacity and Diastolic Function Among Coronary Artery Disease Men With and Without Type 2 Diabetes.. Metab Syndr Relat Disord 2019; 17(3):149-159.
Ferreira-Neto AN, Merten C, Beurich HW, Zachow D, Richardt G, Larose E, Guimaraes L, Pibarot P, Pelletier-Beaumont E, Rodés-Cabau J, Abdel-Wahab M.. Effect of Aortic Regurgitation by Cardiovascular Magnetic Resonance After Transcatheter Aortic Valve Implantation.. Am J Cardiol 2019; 124(1):78-84.
Anand SS, Tu JV, Desai D, Awadalla P, Robson P, Jacquemont S, Dummer T, Le N, Parker L, Poirier P, Teo K, Lear SA, Yusuf S, Tardif JC, Marcotte F, Busseuil D, Després JP, Black SE, Kirpalani A, Parraga G, Noseworthy MD, Dick A, Leipsic J, Kelton D, Vena J, Thomas M, Schulze KM, Larose E, Moody AR, Smith EE, Friedrich MG; Canadian Alliance for Healthy Hearts and Minds Cohort. Cardiovascular risk scoring and magnetic resonance imaging detected subclinical cerebrovascular disease.. Eur Heart J Cardiovasc Imaging 2020; 21(6):692-700.
Wintzer-Wehekind J, Larose E, Rodés-Cabau J, Barbeau G. Coronary Stent Protruding in the Ascending Aorta: Multimodality Imaging Evaluation.. JACC Cardiovasc Interv 2020; 13(2):263-264.
Tastet L, Kwiecinski J, Pibarot P, Capoulade R, Everett RJ, Newby DE, Shen M, Guzzetti E, Arsenault M, Bédard É, Larose E, Beaudoin J, Dweck M, Clavel MA. Sex-Related Differences in the Extent of Myocardial Fibrosis in Patients With Aortic Valve Stenosis.. JACC Cardiovasc Imaging 2020; 13(3):699-711.
Chartrand DJ, Larose E, Poirier P, Mathieu P, Alméras N, Pibarot P, Lamarche B, Rhéaume C, Després JP. Visceral adiposity and liver fat as mediators of the association between cardiorespiratory fitness and plasma glucose-insulin homeostasis.. Am J Physiol Endocrinol Metab 2020; 319(3):E548-E556.
Steinberg C, Nadeau-Routhier C, André P, Philippon F, Sarrazin JF, Nault I, O'Hara G, Blier L, Molin F, Plourde B, Roy K, Larose E, Arsenault M, Champagne J. Ventricular Arrhythmia in Septal and Apical Hypertrophic Cardiomyopathy: The French-Canadian Experience.. Front Cardiovasc Med 2020; 7(0):548564.
Guzzetti E, Capoulade R, Tastet L, Garcia J, Le Ven F, Arsenault M, Bédard É, Larose E, Clavel MA, Pibarot P.. Estimation of Stroke Volume and Aortic Valve Area in Patients With Aortic Stenosis: A Comparison of Echocardiography Versus Cardiovascular Magnetic Resonance.. J Am Soc Echocardiogr 2020; 33(8):953-963.e5.
Guzzetti E, Tastet L, Annabi MS, Capoulade R, Shen M, Bernard J, García J, Le Ven F, Arsenault M, Bédard É, Larose E, Clavel MA, Pibarot P.. Effect of Regional Upper Septal Hypertrophy on Echocardiographic Assessment of Left Ventricular Mass and Remodeling in Aortic Stenosis.. J Am Soc Echocardiogr 2021; 34(1):62-71.
Nunes Ferreira-Neto A, Merten C, Beurich HW, Zachow D, Richardt G, Larose E, Guimaraes L, Pibarot P, Pelletier-Beaumont E, Rodés-Cabau J, Abdel-Wahab M. Hemodynamic performance of the balloon-expandable SAPIEN 3 valve as assessed by cardiac magnetic resonance.. Int J Cardiol 2020; 320(0):128-132.
Chow BJW, Coyle D, Hossain A, Laine M, Hanninen H, Ukkonen H, Rajda M, Larose E, Hartikainen J, Mielniczuk L, Kass M, Connelly KA, O'Meara E, Garrard L, Bishop H, Small G, Hedman M, Coyle K, Yla-Herttuala S, Knuuti J, Wells GA, Beanlands RS. Computed tomography coronary angiography for patients with heart failure (CTA-HF): a randomized controlled trial (IMAGE-HF 1C).. Eur Heart J Cardiovasc Imaging 2021; 22(9):1083-1090.
Cardinal MP, Blais S, Dumas A, Hamilton V, Larose E, LeBlanc S, Déry J, Grotenhuis H, Leiner T, Mawad W, Têtu C, Greenway SC, Dahl N, Patton D, Hussain A, Drolet C, Gahide G, Farand P, Schantz D, Dallaire F. Novel Z Scores to Correct Biases Due to Ventricular Volume Indexing to Body Surface Area in Adolescents and Young Adults.. Can J Cardiol 2021; 37(3):417-424.
Luu JM, Sergeant AK, Anand SS, Desai D, Schulze K, Knoppers BM, Zawati MH, Smith EE, Moody AR, Black SE, Larose E, Marcotte F, Kleiderman E, Tardif JC, Lee DS, Friedrich MG; CAHHM Study Investigators.. The impact of reporting magnetic resonance imaging incidental findings in the Canadian alliance for healthy hearts and minds cohort.. BMC Med Ethics 2021; 22(1):145.
Paterson DI, Wells G, Erthal F, Mielniczuk L, O'Meara E, White J, Connelly KA, Knuuti J, Radja M, Laine M, Chow BJW, Kandolin R, Chen L, Dick A, Dennie C, Garrard L, Ezekowitz J, Beanlands R, Chan KL; IMAGE-HF Investigators (Larose E, Pibarot P parmi les collaborateurs).. OUTSMART HF: A Randomized Controlled Trial of Routine Versus Selective Cardiac Magnetic Resonance for Patients With Nonischemic Heart Failure (IMAGE-HF 1B).. Circulation 2020; 141(10):818-827.
Harper AR, Bowman M, Hayesmoore JBG, Sage H, Salatino S, Blair E, Campbell C, Currie B, Goel A, McGuire K, Ormondroyd E, Sergeant K, Waring A, Woodley J, Kramer CM, Neubauer S, Farrall M, Watkins H, Thomson KL; HCMR Investigators (Larose E parmi les collaborateurs).. Reevaluation of the South Asian MYBPC3Δ25bp Intronic Deletion in Hypertrophic Cardiomyopathy.. Circ Genom Precis Med 2020; 13(3):e002783.
Garau G, Bataille Y, Larose E, Hoffer E. Incidental detection of myocardial clefts in a patient with acute inferior ST-segment elevation myocardial infarction: a very unusual and potentially ominous association-a case-report.. Eur Heart J Case Rep 2021; 5(1):ytaa472.
Guzzetti E, Racine HP, Tastet L, Shen M, Larose E, Clavel MA, Pibarot P, Beaudoin J. Accuracy of stroke volume measurement with phase-contrast cardiovascular magnetic resonance in patients with aortic stenosis.. J Cardiovasc Magn Reson 2021; 23(1):124.
Sengupta PP, Shrestha S, Kagiyama N, Hamirani Y, Kulkarni H, Yanamala N, Bing R, Chin CWL, Pawade TAm Messika-Zeitoun D, Tastet L, Shen M, Newby DE, Clavel MA, Pibarot P, Dweck MR; Artificial Intelligence for Aortic Stenosis at Risk International Consortium (Larose E, Bernier M, Beaudoin J, Arsenault M parmis les collaborateurs). A Machine-Learning Framework to Identify Distinct Phenotypes of Aortic Stenosis Severity. JACC Cardiovasc Imaging 2021; 14(9):1707-1720.
Drouin-Chartier JP, Tremblay AJ, Godbout D, Gagnon A, Clavel MA, Clisson M, Arsenault BJ, Pibarot P, Larose E, Couture P. Correlates of Coronary Artery Calcification Prevalence and Severity in Patients With Heterozygous Familial Hypercholesterolemia.. CJC Open 2021; 3(1):62-70.
Harper AR, Goel A, Grace C, Thomson KL, Petersen SE, Xu X, Waring A, Ormondroyd E, Kramer CM, Ho CY, Neubauer S, Tadros R, Ware JS, Bezzina CR, Farrall M, Watkins H; ; HCMR Investigators (Larose E parmi les collaborateurs). Common genetic variants and modifiable risk factors underpin hypertrophic cardiomyopathy susceptibility and expressivity.. Nat Genet 2021; 53(2):135-142.
Bernard J, Tastet L, Capoulade R, Shen M, Clisson M, Guzzetti E, Larose E, Arsenault M, Bédard É, Côté N, Clavel MA, Pibarot P. Left ventricular asymmetric remodeling and subclinical left ventricular dysfunction in patients with calcific aortic valve stenosis - Results from a subanalysis of the PROGRESSA study.. Int J Cardiol 2021; 332(0):148-156.
Luu JM, Gebhard C, Ramasundarahettige C, Desai D, Schulze K, Marcotte F, Awadalla P, Broet P, Dummer T, Hicks J, Larose E, Moody A, Smith EE, Tardif JC, Teixeira T, Teo KK, Vena J, Lee DS, Anand SS, Friedrich MG. Normal sex and age-specific parameters in a multi-ethnic population: a cardiovascular magnetic resonance study of the Canadian Alliance for Healthy Hearts and Minds cohort.. J Cardiovasc Magn Reson 2022; 24(1):2.
Chartrand DJ, Murphy-Després A, Alméras N, Lemieux I, Larose E, Després JP. Overweight, Obesity, and CVD Risk: a Focus on Visceral/Ectopic Fat.. Curr Atheroscler Rep 2022; 24(4):185-195.
Anand SS, Friedrich MG, Lee DS, Awadalla P, Després JP, Desai D, de Souza RJ, Dummer T, Parraga G, Larose E, Lear SA, Teo KK, Poirier P, Schulze KM, Szczesniak D, Tardif JC, Vena J, Zatonska K, Yusuf S, Smith EE. Evaluation of Adiposity and Cognitive Function in Adults.. JAMA Netw Open 2022; 5(2):e2146324.
Chow BJW, Galiwango P, Poulin A, Raggi P, Small G, Juneau D, Kazmi M, Ayach B, Beanlands RS, Sanfilippo AJ, Chow CM, Paterson DI, Chetrit M, Jassal DS, Connelly K, Larose E, Bishop H, Kass M, Anderson TJ, Haddad H, Mancini J, Doucet K, Daigle JS, Ahmadi A, Leipsic J, Lim SP, McRae A, Chou AY. Chest Pain Evaluation: Diagnostic Testing.. CJC Open 2023; 5(12):891-903.
Rauzier C, Chartrand DJ, Alméras N, Lemieux I, Larose E, Mathieu P, Pibarot P, Lamarche B, Rhéaume C, Poirier P, Després JP, Picard F. Associations of insulin-like growth factor binding protein-2 (IGFBP-2) with metabolic profile and hepatic fat deposition in asymptomatic men and women.. Am J Physiol Endocrinol Metab 2023; 325(1):E99-E105.
Rauzier C, Chartrand DJ, Alméras N, Lemieux I, Larose E, Mathieu P, Pibarot P, Lamarche B, Rhéaume C, Poirier P, Després JP, Picard F. Plasma IGFBP-2 levels reveal heterogeneity in hepatic fat content in adults with excess visceral adiposity.. Front Endocrinol (Lausanne) 2023; 14(0):1222101.
Hundemer GL, Agharazii M, Madore F, Vaidya A, Brown JM, Leung AA, Kline GA, Larose E, Piché ME, Crean AM, Shaw JLV, Ramsay T, Hametner B, Wassertheurer S, Sood MM, Hiremath S, Ruzicka M, Goupil R. Subclinical Primary Aldosteronism and Cardiovascular Health: A Population-Based Cohort Study.. Circulation 2023; 0(0):Epub.
Kumar A, Connelly K, Vora K, Bainey KR, Howarth A, Leipsic J, Betteridge-LeBlanc S, Prato FS, Leong-Poi H, Main A, Atoui R, Saw J, Larose E, Graham MM, Ruel M, Dharmakumar R. The Canadian Cardiovascular Society Classification of Acute Atherothrombotic Myocardial Infarction Based on Stages of Tissue Injury Severity: An Expert Consensus Statement.. Can J Cardiol 2023; 0(0):Epub.

Dr Eric Larose

Domaine de recherche

Description des travaux

Prix et distinctions

Publications

Support tomorrow's medicine, now.